INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 254 filers reported holding INSMED INC in Q3 2023. The put-call ratio across all filers is 6.19 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $949,956 | +20.3% | 37,622 | +0.5% | 0.00% | 0.0% |
| Q2 2023 | $789,604 | +21.1% | 37,422 | -2.1% | 0.00% | 0.0% |
| Q1 2023 | $651,856 | -14.7% | 38,232 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $763,875 | -16.3% | 38,232 | -9.8% | 0.00% | 0.0% |
| Q3 2022 | $913,000 | +9.2% | 42,382 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $836,000 | -16.1% | 42,382 | +0.0% | 0.00% | 0.0% |
| Q1 2022 | $996,000 | -19.0% | 42,372 | -6.1% | 0.00% | 0.0% |
| Q4 2021 | $1,230,000 | +0.7% | 45,142 | +1.8% | 0.00% | 0.0% |
| Q3 2021 | $1,222,000 | -3.2% | 44,358 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $1,262,000 | -4.7% | 44,358 | +14.1% | 0.00% | -33.3% |
| Q1 2021 | $1,324,000 | -4.2% | 38,872 | -6.4% | 0.00% | 0.0% |
| Q4 2020 | $1,382,000 | +2.5% | 41,522 | -1.0% | 0.00% | 0.0% |
| Q3 2020 | $1,348,000 | +18.8% | 41,952 | +1.8% | 0.00% | 0.0% |
| Q2 2020 | $1,135,000 | +72.0% | 41,202 | 0.0% | 0.00% | +50.0% |
| Q1 2020 | $660,000 | -32.9% | 41,202 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $984,000 | +35.4% | 41,202 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $727,000 | -31.1% | 41,202 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $1,055,000 | -7.6% | 41,202 | +4.9% | 0.00% | 0.0% |
| Q1 2019 | $1,142,000 | +121.3% | 39,292 | 0.0% | 0.00% | +50.0% |
| Q4 2018 | $516,000 | -33.6% | 39,292 | +2.2% | 0.00% | 0.0% |
| Q3 2018 | $777,000 | -14.5% | 38,450 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $909,000 | +13.3% | 38,450 | +7.9% | 0.00% | 0.0% |
| Q1 2018 | $802,000 | -26.4% | 35,620 | +2.0% | 0.00% | -33.3% |
| Q4 2017 | $1,089,000 | +17.9% | 34,921 | +18.0% | 0.00% | 0.0% |
| Q3 2017 | $924,000 | +81.9% | 29,601 | 0.0% | 0.00% | +200.0% |
| Q2 2017 | $508,000 | -1.4% | 29,601 | +0.6% | 0.00% | 0.0% |
| Q1 2017 | $515,000 | +32.4% | 29,435 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $389,000 | -8.9% | 29,435 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $427,000 | +47.8% | 29,435 | +0.3% | 0.00% | 0.0% |
| Q2 2016 | $289,000 | -21.5% | 29,335 | +1.0% | 0.00% | 0.0% |
| Q1 2016 | $368,000 | -30.2% | 29,057 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $527,000 | +0.4% | 29,057 | +2.7% | 0.00% | 0.0% |
| Q3 2015 | $525,000 | -16.7% | 28,297 | +9.6% | 0.00% | 0.0% |
| Q2 2015 | $630,000 | +20.9% | 25,807 | +3.0% | 0.00% | 0.0% |
| Q1 2015 | $521,000 | +50.6% | 25,056 | +12.1% | 0.00% | +100.0% |
| Q4 2014 | $346,000 | +18.5% | 22,351 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $292,000 | -34.7% | 22,351 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $447,000 | +38.4% | 22,351 | +31.7% | 0.00% | 0.0% |
| Q1 2014 | $323,000 | +13.3% | 16,974 | +1.1% | 0.00% | 0.0% |
| Q4 2013 | $285,000 | +8.8% | 16,784 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $262,000 | +30.3% | 16,784 | 0.0% | 0.00% | 0.0% |
| Q2 2013 | $201,000 | – | 16,784 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |